20th week of 2022 patent applcation highlights part 26 |
Patent application number | Title | Published |
20220153634 | COATED SUBSTRATE AND PROCESS OF PREPARATION - A coated glass substrate comprising: a transparent glass substrate coated with a blocking layer comprising a material having Si—O—Si bonds and a blocking component, wherein the blocking component comprises fluorone and/or a fluorone derivative. | 2022-05-19 |
20220153635 | GLASS ARTICLE HAVING AN ANTI-REFLECTIVE COATING - A glass article includes a glass substrate with a coating formed over the glass substrate. The coating includes a first anti-reflective layer deposited over the glass substrate, the first layer having a refractive index of 1.6 or more and a thickness of less than) λ/(4*n). A second anti-reflective layer is deposited over the first anti-reflective layer, the second anti-reflective layer having a thickness that is greater than the thickness of the first anti-reflective layer and a refractive index that is less than the refractive index of the first anti-reflective layer. The glass article exhibits a total visible light reflectance of less than 6.0%. | 2022-05-19 |
20220153636 | COATED ARTICLE AND METHOD FOR MANUFACTURING THE SAME - A coated article includes a transparent substrate, a multilayer thin film coating disposed on the transparent substrate, and a patterned area having an enamel coating formed on at least part of the transparent substrate in a predetermined pattern, wherein the multilayer thin film coating includes a first dielectric layer, a metallic functional layer having an infrared ray reflection function, and a second dielectric layer, which are sequentially disposed in a direction away from the transparent substrate, and the patterned area includes the first dielectric layer remaining on the substrate after the second dielectric layer and the metallic functional layer are removed from the multilayer thin film coating, and the enamel coating formed on the first dielectric layer. | 2022-05-19 |
20220153637 | TOP PLATE FOR COOKING DEVICE AND TOP PLATE FOR DISPLAY-ATTACHED COOKING DEVICE - Provided is a top plate for a cooking device capable of making the indication in a displaying region clearly visible during turn-on of a display and, during turn-off of the display, capable of making the boundary between the displaying region and a non-displaying region less visible while hiding the internal structure of the cooking device. A top plate | 2022-05-19 |
20220153638 | MICROFABRICATION METHOD - A microfabrication method is provided with which it is possible to easily form a fine periodic structure on a surface of any substrate. A glass precursor is applied to a substrate, and the glass precursor is irradiated with short-pulse laser light. By the irradiation with short-pulse laser light, the glass precursor is activated to undergo a thermal reaction, and a fine periodic structure can be easily formed on the surface. Furthermore, by oxidizing the substrate on which the fine periodic structure has been formed, the hue of the surface can be improved while maintaining the fine periodic structure. | 2022-05-19 |
20220153639 | METHOD AND DEVICE FOR PRODUCING CONDUCTIVE GLASS FIBER MESH WITH LASER INDUCED COATING GRAPHENE - A method for producing a conductive glass fiber mesh with laser induced coating graphene comprises: (I) preparing a glass fiber paper coated with a carbon-containing precursor material; (II) subjecting the glass fiber paper coated with the carbon-containing precursor material to laser irradiation to reduce the carbon-containing precursor material into the laser induced coating graphene, obtaining a glass fiber paper coated with the laser induced coating graphene; and (III) folding the glass fiber paper coated with the laser induced coating graphene to obtain the conductive glass fiber mesh with laser induced coating graphene. | 2022-05-19 |
20220153640 | Particle Size Distribution of Low Carbon Ordinary Portland Cement - There is provided high temperature furnaces, calcining, pyrolysis and other high temperature manufacturing processes, composition rearrangements, and equipment. Generally, embodiments the present inventions relate to systems, equipment and processes using oxyfuel for high temperature processing of materials for the production of cements having a particle size distribution from about 0.1 μm to about 150 μm. | 2022-05-19 |
20220153641 | HYALOCLASTITE, SIDEROMELANE OR TACHYLITE POZZOLAN-BASED GEOPOLYMER CEMENT AND CONCRETE AND METHOD OF MAKING AND USING SAME - The invention comprises a cementitious material comprising a natural pozzolan selected from hyaloclastite, sideromelane or tachylite, wherein the natural pozzolan has a volume-based mean particle size of less than or equal to 40 μm. The cementitious material also comprising an aqueous alkaline activating solution suitable for forming a geopolymer. A method making a cementitious material is also disclosed. | 2022-05-19 |
20220153642 | WASTEWATER TREATMENT SYSTEM AND METHOD FOR PRODUCING SLUDGE FOR CEMENT MANUFACTURING - A wastewater treatment system, including a wastewater phase-separation device, may be used to combine at least one primary treatment chemical and wastewater to produce cleaned water and a sludge byproduct. The wastewater treatment system may also include a wastewater dewatering device that may be used to combine the sludge byproduct and at least one secondary treatment chemical to produce a Medium to High Solids Content Sludge without excess water. A method for producing sludge for cement manufacturing may include combining wastewater and at least one primary treatment chemical to form a liquid phase and a solid phase, where the liquid phase includes clean water and the solid phase includes a sludge byproduct, separating the liquid phase from the solid phase, combining the solid phase with at least one secondary treatment chemical to form an intermediate that contains excess water, and removing the excess water from the intermediate to form a Medium to High Solids Content Sludge. | 2022-05-19 |
20220153643 | HYALOCLASTITE POZZOLAN, HYALOCLASTITE BASED CEMENT, HYALOCLASTITE BASED CONCRETE AND METHOD OF MAKING AND USING SAME - The invention comprises a composition comprising hyaloclastite having a volume-based mean particle size of less than or equal to 40 μm. The invention also comprises a cementitious material comprising a hydraulic cement and hyaloclastite, wherein the hyaloclastite has a volume-based mean particle size of less than or equal to approximately 40 μm. The invention further comprises a cementitious-based material comprising aggregate, a cementitious material comprising a hydraulic cement and hyaloclastite, wherein the hyaloclastite has a volume-based mean particle size of less than or equal to approximately 40 um and water sufficient to hydrate the cementitious material. A method of using the composition of the present invention is also disclosed. | 2022-05-19 |
20220153644 | SHRINKAGE REDUCER FOR MINERAL BINDER COMPOSITION AND ITS USE - An additive, in particular a shrinkage reducing agent, for mineral binder compositions including at least one super absorbant polymer SAP and at least one defoamer D. Further, a mineral binder composition including the additive, processes and methods for the mixing thereof, and to hardened articles obtainable therefrom. | 2022-05-19 |
20220153645 | MICRO-SURFACING SEALING COAT MIXTURE AND PREPARATION METHOD THEREOF - Disclosed is a micro-surfacing sealing coat mixture, comprising the following raw materials in parts by weight: 10-20 parts of a cationic emulsified asphalt, 5-7 parts of an ethylene-1-octene copolymer, 3-6 parts of an organic silicone resin, 8-12 parts of a filler, 80-90 parts of an aggregate, 2-4 parts of a ditertiarybutyl peroxide, 20-30 parts of water, and 0.5-2 parts of an accelerator. The method for preparing the micro-surfacing sealing coat mixture comprises: weighing raw materials other than the filler, aggregate and water, adding to a high-speed shear emulsifier and mixing at a temperature of 170-175° C. for 20-35 min, then continuously shearing at 3000-3500 r/min for 60 min to obtain a modified emulsified asphalt; cooling the modified emulsified asphalt to 20-30° C., adding the filler, aggregate and water thereto, and adding the resulting mixture to a mixer to mix evenly to obtain the micro-surfacing sealing coat mixture. | 2022-05-19 |
20220153646 | ADHESIVE COMPOSITION - An adhesive composition, in particular a tile adhesive, includes: a) 10-50 wt. % of a hydraulic binder, b) 20-60 wt. % of lightweight aggregates, c) 10-25 wt. % of a polymer. | 2022-05-19 |
20220153647 | CARBONATION OF REACTIVE MAGNESIA CEMENT (RMC)-BASED SYSTEMS - Herein discloses a method of carbonating reactive magnesia cement, which includes: (i) providing an aqueous suspension including a carbon dioxide-producing bacteria; (ii) mixing the aqueous suspension with a precursor which the carbon dioxide-producing bacteria generates carbon dioxide from for a duration to form an aqueous mixture sufficient for substantially carbonating the reactive magnesia cement; (iii) mixing the aqueous mixture with the reactive magnesia cement to form a blend; wherein a nutrient is provided in the aqueous suspension of step (i) or in the reactive magnesia cement of step (iii) to sustain the carbon dioxide-producing bacteria in the reactive magnesia cement; and (iv) curing the blend to carbonate the reactive magnesia cement. A reactive magnesia cement composite formed by the method is also disclosed. | 2022-05-19 |
20220153648 | THERMAL INSULATION MATERIAL AND METHOD OF APPLICATION THEREOF - A thermal insulation material, a process for producing the thermal insulation material and an application process of the material on surfaces is disclosed. The thermal insulation material contains 30-90 wt % aluminum silicate source and 1-30 wt % inorganic hollow material particles. The aluminum silicate source has fly ash and/or clay based material. | 2022-05-19 |
20220153649 | ZIRCONIA SINTERED BODY HAVING HIGH LINEAR LIGHT TRANSMITTANCE - A zirconia sintered body may excel in translucency, strength, and linear light transmittance with no use of an HIP device, and a zirconia molded body and a zirconia pre-sintered body from which such a zirconia sintered body can be obtained. A zirconia molded body may include zirconia particles with 2.0 to 9.0 mol % yttria, an average primary particle diameter of 60 nm or less, and 0.5 mass % or less zirconia particles having a particle diameter >100 nm, wherein the zirconia molded body has ΔL*(W−B) of 5+ through a thickness of 1.5 mm. A zirconia pre-sintered body may include 2.0 to 9.0 mol % yttria, and have a ΔL*(W−B) of 5+ through a thickness of 1.5 mm. A zirconia sintered body may include: a fluorescent agent; 2.0 to 9.0 mol % yttria, and have a linear light transmittance of 1% or more through a thickness of 1.0 mm. | 2022-05-19 |
20220153650 | SINTERED ALUMINA-ZIRCONIA BALLS - Sintered bead that has a crystalline composition, as percentages by weight based on the total weight of the crystalline phases: zircon<25%; 50%≤cubic zirconia+tetragonal zirconia≤95%, the cubic zirconia content being greater than 50%, the cubic zirconia content being the (cubic zirconia/(cubic zirconia+tetragonal zirconia) ratio by weight); 0≤monoclinic zirconia≤(10−0.2*tetragonal zirconia) %; 5%≤corundum≤50%; crystalline phases other than zircon, cubic zirconia, tetragonal zirconia, monoclinic zirconia and corundum<10%; and the following chemical composition, as percentages by weight based on the oxides: 34%≤ZrO | 2022-05-19 |
20220153651 | CUBIC BORON NITRIDE SINTERED MATERIAL - A cubic boron nitride sintered material includes: more than or equal to 80 volume % and less than or equal to 96 volume % of cubic boron nitride grains; and a binder, wherein the binder includes tungsten carbide, cobalt, and an aluminum compound, and Ha/Hb≥0.40 is satisfied, where Hb represents a hardness of the cubic boron nitride sintered material and Ha represents a hardness of the cubic boron nitride sintered material after performing acid treatment onto the cubic boron nitride sintered material to substantially remove the binder in the cubic boron nitride sintered material. | 2022-05-19 |
20220153652 | RAPID PROCESSING OF LAMINAR COMPOSITE COMPONENTS - A method of manufacturing a CMC structure includes infiltrating a porous substrate with a composite material and performing a first densification on the infiltrated porous substrate, forming a first densified porous substrate, wherein the first densification includes techniques selected from the group of techniques comprising photonic curing, photonic sintering, pulsed thermal heating, or combinations thereof. | 2022-05-19 |
20220153653 | Biochar Suspended Solution - A method is provided for producing a biochar solution. The method comprises the steps of collecting biochar particles, dispersing the biochar particles in a liquid solution and adding a stabilizing agent to keep the biochar in flowable suspension. The stabilizing agent may be added to the liquid solution or to the biochar prior to placing the biochar in solution. | 2022-05-19 |
20220153654 | Polyester polyol with high biomass ratio for polyurethane controlled-release fertilizer envelope, preparation method thereof and envelope - Epoxy soybean oil polyol is firstly prepared by open-ring etherification of an epoxy soybean oil and a small molecular alcohol with an organic acid catalyst, and then the epoxy soybean oil polyol is further esterified with an organic acid under an esterification catalyst to prepare a polyester polyol with a high biomass ratio. The polyester polyol includes a compound having an Ñ-type structure and a compound having an Ò-type structure. A method for preparing the polyester polyol is provided, as well as a polyurethane controlled-release fertilizer envelope and a polyurethane controlled-release fertilizer prepared by cross-linking the polyester polyol and MDI on surfaces of the fertilizer. The epoxy soybean oil and the small molecular alcohol can be derived from biomass, so a biomass content is high, the synthesized product is environmentally safe, and product performance is excellent. | 2022-05-19 |
20220153655 | NITRIFICATION INHIBITORS - Nitrification inhibitors and uses of same to prevent nitrate leaching or nitrous oxide emissions as well as increase pasture or crop production. The nitrification inhibitors and formulations including same may be used for direct or indirect application to soil or pasture. | 2022-05-19 |
20220153656 | SYSTEM AND METHOD FOR CARBON DIOXIDE REACTOR CONTROL - A system optionally including a carbon oxide reactor. A method for carbon oxide reactor control, optionally including selecting carbon oxide reactor aspects based on a desired output composition, running a carbon oxide reactor under controlled process conditions to produce a desired output composition, and/or altering the process conditions to alter the output composition. | 2022-05-19 |
20220153657 | METHODS AND SYSTEMS FOR CONVERTING CARBON OXIDES TO OLEFINS - A method of converting carbon oxides to olefins is provided. The method can include directing a renewable hydrogen feed stream and a carbon oxide feed stream to a methanation reactor to generate an oxidative coupling of methane (OCM) feed stream that includes methane. The OCM feed stream and an oxidant feed stream including oxygen are directed to an OCM reactor containing an OCM catalyst to produce an OCM effluent that includes ethylene. A system for converting carbon oxides to olefins is also provided. The methods and systems produce olefins including ethylene with negative carbon emissions. | 2022-05-19 |
20220153658 | Integration of a Steam Cracker with Acid Alkylation - Methods and systems for steam cracking a mixed butane containing feed stream are disclosed. The feed stream includes n-butane and isobutane. The disclosed methods and systems entail splitting the feed into an enriched n-butane fraction and an enriched isobutane fraction. The enriched n-butane fraction is provided to the cracking furnaces, which yield the olefin products and also yield C4 species. The C4 species are partially hydrogenated and provided as a reactant feed to an alkylation reaction. The enriched isobutane fraction is also provided to the alkylation reaction, whereby high value alkylate product is produced. The disclosed methods and systems have increase olefins (especially ethylene) yield because the feed to the cracking process is enriched in n-butane. The economics are also improved because high value alkylate product is produced from a portion of the isobutane. | 2022-05-19 |
20220153659 | Processes and Systems for Converting Benzene and/or Toluene via Methylation - This disclosure provides an improved process for converting benzene/toluene via methylation with methanol/dimethyl ether for producing, e.g., p-xylene, comprising separating and recycling dimethyl ether from the methylation reaction product mixture effluent to the methylation reactor. High selectivity toward p-xylene, among others, can be achieved. | 2022-05-19 |
20220153660 | Processes for Converting Benzene and/or Toluene Via Methylation - This disclosure provides improved processes for converting benzene/toluene via methylation with methanol/dimethyl ether for producing, e.g., p-xylene. In an embodiment, a process comprises contacting a methylation agent feed with an aromatic hydrocarbon feed in the presence of a methylation catalyst in a methylation reactor at increased pressure. Reduced methylation catalyst deactivation can be achieved with increased pressure in the methylation reactor. | 2022-05-19 |
20220153661 | METHOD AND SYSTEM FOR PRODUCING ONE OR MORE OLEFINS - A process ( | 2022-05-19 |
20220153662 | METHOD FOR THE PURIFICATION OF ALKANES - The present invention relates to a method for the purification of alkanes, especially methane, wherein an alkane comprising impurities, especially methane, is reacted with an active compound, optionally in the presence of sulfur trioxide, whereby the impurities are removed. The present invention furthermore relates to the use of the active compound and sulfur trioxide in the purification of alkanes, especially methane. | 2022-05-19 |
20220153663 | VEHICULAR VISION SYSTEM WITH CONSOLE VIDEO DISPLAY AND MIRROR VIDEO DISPLAY FOR EXTERIOR VIEWING CAMERAS - A vehicular display system includes an electronic control unit (ECU) and a plurality of cameras disposed at the vehicle. The cameras capture image data and provide captured image data to the ECU. The system includes a video display screen and a video mirror display screen that are operable to display video images derived from video images provided by the ECU. When the vehicle is traveling forward at a speed below a threshold speed, the ECU generates rearward view video images derived from image data captured by a rearward viewing camera and provides the rearward view video images to the video display screen. When the vehicle is traveling forward at a speed at or above the threshold speed, the ECU generates rearward view video images derived from image data captured by a rearward viewing camera and provides the rearward view video images to the video mirror display screen. | 2022-05-19 |
20220153664 | OLEFIN COMPOUND PRODUCTION METHOD - Provided is a method for producing an olefin compound using reaction with a base, whereby a target product with a higher purity than the prior art can be obtained. Specifically, provided is a method for producing an olefin compound by reacting a phosphorus-containing olefin compound salt with a base to obtain a dephosphorized and hydrogenated olefin compound, wherein the temperature of the reaction is 50° C. or less. | 2022-05-19 |
20220153665 | METHOD FOR PURIFYING 1-CHLORO-3,3,3-TRIFLUOROPROPENE - The present invention relates to a process for purifying 1-chloro-3,3,3-trifluoropropene comprising the steps of: a) providing a stream comprising 1-chloro-3,3,3-trifluoropropene and at least one compound of formula HX wherein X is F or Cl; b) bringing the stream from step a) into contact with a solution A comprising at least one sulfite salt of formula Y | 2022-05-19 |
20220153666 | SOLVENT COMPOSITION, CLEANING METHOD, METHOD OF FORMING A COATING FILM, HEAT TRANSFER FLUID, AND HEAT CYCLE SYSTEM - The present invention is a solvent composition including: a solvent including 1-chloro-2,3,3-trifluoro-1-propene; and at least one type of stabilizer selected from a group consisting of phenols, ethers, epoxides, amines, alcohols, and hydrocarbons, and is a solvent composition which is excellent in solubility of various organic substances and has no adverse effect on a global environment, and is excellent in stability, and this solvent composition can be used for a wide range of industrial uses such as cleaning, coating uses, and a heat transfer fluid. | 2022-05-19 |
20220153667 | METHOD FOR PRODUCING DIOL - [Objective] An object is to provide a method for producing a diol by which diols having a favorable color scale and containing a reduced amount of an unsaturated aliphatic hydrocarbon can be produced. | 2022-05-19 |
20220153668 | COMPOSITION - A method for preparing a partially fluorinated alcohol, comprises reacting an epoxide: wherein R | 2022-05-19 |
20220153669 | CELLULOSIC COMPLEX AND APPLICATIONS THEREOF - The present invention provides a polysaccharide supported fluorinating agents which can be used in fluorination reactions. The invention particularly describes a new bacterial cellulose supported tetra-n-butyl ammonium fluoride complex [NBu4(Bac-Cell-OH)F] which is stable and non-hygroscopic. The invention further relates to a process for fluorination using the [NBu4(Bac-Cell-OH)F] complex. | 2022-05-19 |
20220153670 | Cannabinoid Emulsifier - Provided herein is a compound which is particularly suitable for use as a cannabinoid, as an emulsifier for a cannabinoid, in a formulation comprising the compound and in a method of treatment using the compound. The compound is defined by the General Formula: | 2022-05-19 |
20220153671 | METHOD FOR PRODUCING ALPHA-ALLYLATED CYCLOALKANONE - Provided is a method with which an α-allylated cycloalkanone is obtained from a cyclic compound cycloalkanone used as a starting material. The method is a method for producing an α-allylated cycloalkanone represented by General Formula (III), and the method includes: a step 1: reacting a compound represented by General Formula (I) and alcohol having 1 or more and 4 or less of carbon atoms in the presence of a first acid catalyst and optionally a dehydrating agent; and a step 2: reacting a crude product obtained in the step 1 and a compound represented by General Formula (II) in the presence of a second acid catalyst to produce an α-allylated cycloalkanone represented by General Formula (III). The step 1 and the step 2 are consecutively performed. In the formulae above, the group -A | 2022-05-19 |
20220153672 | METHOD FOR PRODUCING ALPHA-ALLYLATED CYCLOALKANONE - Provided is a method with which an α-allylated cycloalkanone is obtained from a macroyclic compound used as a starting material. The method is a method for producing an α-allylated cycloalkanone represented by General Formula (IV), and the method includes a step of reacting a compound represented by General Formula (I) and/or a compound represented by General Formula (II) with a compound represented by General Formula (III) in the presence of an acid catalyst to produce an α-allylated cycloalkanone represented by General Formula (IV), the acid catalyst including an acid catalyst that includes an ammonium cation and an anion. | 2022-05-19 |
20220153673 | METHODS FOR SEPARATION OF AZEOTROPE OR AZEOTROPE-LIKE COMPOSITIONS OF TRIFLUOROIODOMETHANE (CF3I) AND TRIFLUOROACETYL CHLORIDE (CF3COCI) - The present disclosure provides azeotrope or azeotrope-like compositions including trifluoroiodomethane (CF | 2022-05-19 |
20220153674 | Degradation Of Plastic Materials Into Terephthalic Acid (TPA), Ethylene Glycol And/Or Other Monomers That Form The Plastic Materials - The invention relates to a method for degradation of plastic materials into terephthalic acid (TPA) and/or ethylene glycol and/or other monomers that form the plastic materials. | 2022-05-19 |
20220153675 | SALTS OF TREPROSTINIL - Provided are novel treprostinil salts as well as methods for making treprostinil salts. | 2022-05-19 |
20220153676 | RECOVERY OF 3-HYDROXYPROPIONIC ACID - A method for recovering a composition enriched in 3-hydroxypropionic acid from a fermentation broth comprising 3-hydroxypropionic acid and/or salts thereof comprises the steps of: (a) providing the fermentation broth having a pH of from about 2 to about 8 comprising: 3-hydroxypropionic acid and/or salts thereof, (b) acidifying the fennentation broth; (c) reducing the total sulfate ion and phosphate ion (d) distilling the resulting reduced ion aqueous solution and (e) recovering the product. | 2022-05-19 |
20220153677 | RECOVERY OF 3-HYDROXYPROPIONIC ACID - A method for recovering a composition enriched in 3-hydroxypropionic acid by providing the fermentation broth, acidifying the fermentation broth; reducing the total sulfate ion and phosphate ion concentration of the resulting gaseous solution to produce a reduced ion aqueous solution; distilling the resulting reduced ion aqueous solution and recovering the resulting aqueous distillation product comprising 3-hydroxypropionic acid | 2022-05-19 |
20220153678 | Sebacic acid by-product fatty acid polyester polyol for polyurethane controlled-release fertilizer envelope, preparation method thereof and envelope - A polyester polyol is synthesized through an esterification reaction with a sebacic acid by-product fatty acid as a raw material; wherein the sebacic acid by-product fatty acid is refined from a by-product produced during preparing a sebacic acid from a castor oil; the sebacic acid by-product fatty acid includes, in weight percentage: a palmitic acid 15-25%, a stearic acid 10-16%, an oleic acid 45-57%, and a linoleic acid 12-28%. A method for preparing the polyester polyol is provided, as well as a polyurethane controlled-release fertilizer envelope and a polyurethane controlled-release fertilizer. The sebacic acid by-product fatty acid is used as a raw material to synthesize the polyester polyol because of a low price. The prepared fertilizer has excellent envelope and controlled-release performance, product structure performance is stable, cost performance is high, and degradation performance is sufficient after being applied to soil. | 2022-05-19 |
20220153679 | ACID CATALYZED SYNTHESIS OF METHYL ACRYLATE FROM ACRYLIC ACID AND METHANOL - A method for preparing methyl acrylate comprises heating in a reaction zone a mixture comprising acrylic acid, methanol, and an acid catalyst to react and form a reaction product comprising methyl acrylate which is vaporized with other light components and then fed to a distillation zone. A feed stream entering the reaction zone comprises methanol and acrylic acid in a molar ratio of greater than 1 and less than 2, and a residence time in the reaction zone ranges from 0.25 to 2 hours. A distillate from the distillation zone is condensed and phase-separated to form an organic phase comprising methyl acrylate and an aqueous phase. A portion of the organic phase is returned to the distillation zone as organic reflux. The remainder of the organic phase and the aqueous phase of the distillation zone is fed to an extraction column to form a methanol rich aqueous effluent and an organic effluent comprising methyl acrylate. The organic effluent from the extraction column is purified in a single finishing column, wherein a light ends stream is removed from the top of the finishing column, a bottoms stream is removed from the bottom of the finishing column, and methyl acrylate is removed from a side draw stream. | 2022-05-19 |
20220153680 | Catalytic Conversion of Lignocellulosic Biomass Into Industrial Biochemicals - This invention relates to a method for the conversion of lignocellulosic biomass into ethyl esters of carboxylic acids. Said method consists of treating the biomass material with an oxidizing agent that is incorporated in an solution comprising one or more acids, one or more alcohols and water, and subsequently performing a catalytic reaction at a higher temperature using the same acidic solution into which a larger volume of alcohol is added, in such a way that the catalytic conversion occurs in a medium with a much higher concentration of alcohol, i.e. with a much higher alcohol-to-water wt ratio. Such a method results in relatively high yields of ethyl esters, such as ethyl esters of formic, acetic, and levulinic acids, while producing a low yield of dialkyl ethers, which are unwanted by-products. The concentration of the oxidizing agent in the pre-treatment step is preferably higher than 6.0 wt %. The oxidizing agent is preferably a Fenton or Fenton-type reagent, and most preferably hydrogen peroxide activated by Fe (II), and/or Ti (IV) ions. The alcohol is preferably ethanol, and when ethanol is used, diethyl ether is formed as the unwanted dialkyl ether by-product. Preferably, the biomass material is pelleted before treatment. | 2022-05-19 |
20220153681 | ISOBUTYRIC ACID ESTER COMPOUND HAVING N-BUTYRYLOXY AT a-POSITION, PERFUME COMPOSITION, AND USE AS PERFUME - A compound, represented by Formula (1): wherein, in Formula (1), R represents a linear, branched, or cyclic alkyl group having 1 to 4 carbon atoms. | 2022-05-19 |
20220153682 | METHOD FOR PRODUCING XYLYLENEDIAMINE - A method for producing xylylenediamine, including performing a first hydrogenation including hydrogenating a mixed solution including dicyanobenzene and a solvent including liquid ammonia in a fixed-bed reactor such that a reaction product (A) is produced, performing ammonia separation including separating and removing liquid ammonia included in the reaction product (A) or a reaction product (D) such that a reaction product (B) or (E) is produced, performing solid-liquid separation including subjecting the reaction product (B) or (A) to solid-liquid separation and removing a solid component such that a reaction product (C) or the reaction product (D) is produced, and performing a second hydrogenation including hydrogenating the reaction product (C) or (E) in a fixed-bed reactor. After the first hydrogenation is performed, the ammonia separation and the solid-liquid separation are performed in this order or reverse order, followed by the second hydrogenation. | 2022-05-19 |
20220153683 | METHOD FOR PRODUCING HETERO-TYPE MONODISPERSE POLYETHYLENE GLYCOL DERIVATIVE - The present invention provides a method for producing a hetero-type monodisperse polyethylene glycol, which includes a step (A) of carrying out a nucleophilic substitution reaction between a compound of the formula (2) and a compound of the formula (3) so as to satisfy the requirement of the expression (F1) to obtain a compound of the formula (4), a step (B) of carrying out the Michaels addition reaction of a compound of the formula (5) to the compound of the formula (4) at a temperature condition of 10° C. or lower to obtain a compound of the formula (6), a step (C) of detritylating or debenzylating the compound of the formula (6) to obtain a reaction product containing a compound of the formula (7), a step (D) of purifying the compound of formula (7) from the reaction product, a step (E) of reacting the compound of the formula (7) with phthalimide and performing dephthalimidation to obtain a compound of the formula (8), and a step (F) of subjecting the compound of formula (8) to an acid hydrolysis treatment to obtain a compound represented by the formula (1). | 2022-05-19 |
20220153684 | PROCESS FOR PREPARATION OF FINGOLIMOD HYDROCHLORIDE - The present invention relates to a process for the preparation of the active pharmaceutical ingredient Fingolimod Hydrochloride (I) and its highly pure intermediate [2-acetamido-2-(acetyloxy methyl)-4-phenylbutyl] acetate(II) | 2022-05-19 |
20220153685 | SMALL MOLECULE AMPK ACTIVATORS - Described herein are compounds that disrupt the interaction between Fbxo48 and phosphorylated-AMPK. | 2022-05-19 |
20220153686 | LIPID NANOPARTICLE COMPOSITION - Provided herein are lipids that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid molecules) for therapeutic or prophylactic purposes, including vaccination. | 2022-05-19 |
20220153687 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME - The compounds represented by Formula (I), which are peripheral alkyl and alkenyl chains extended benzene derivatives, are useful as dual autotaxin (ATX)/histone deacetylase (HD AC) inhibitors. These compounds may be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and be used in a therapeutically effective amount for prophylaxis or treatment of various diseases and disorders. | 2022-05-19 |
20220153688 | HYDRAZONE AMIDE DERIVATIVES AND USE THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS DRUGS - Provided are a new class of hydrazone amide derivatives and the use thereof in the preparation of anti-osteoporosis drugs, wherein the structural formula of the hydrazone amide derivative is as shown in formula (I), and same are a new class of compounds with an anti-osteoporosis effect. | 2022-05-19 |
20220153689 | CATALYST, METHOD FOR PRODUCING CATALYST, AND METHOD FOR PRODUCING ACRYLONITRILE - A catalyst comprising Mo, Bi, and Fe, and
| 2022-05-19 |
20220153690 | ELECTROLYTE, AND ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE INCLUDING SAME - An electrolyte including one or more nitrile benzoquinone compounds, and the nitrile benzoquinone compound is selected from the group consisting of the compounds represented by formula I, formula II, and formula III: | 2022-05-19 |
20220153691 | PROCESS FOR THE PREPARATION OF HALOALKANESULFONIC ACIDS FROM SULFUR TRIOXIDE AND A HALOALKANE AT SUPERACIDIC CONDITIONS - The present invention refers to a method for the production of haloalkane sulfonic acid, in which SO | 2022-05-19 |
20220153692 | PROCESS FOR PREPARATION OF TRIFLUOROMETHANESULFINYL CHLORIDE - A process for the preparation of trifluoromethanesulfinyl chloride is provided. Trifluoromethanesulfinyl chloride is used as an intermediate for preparing pesticides and insecticides. Trifluoromethanesulfinyl chloride is represented by Formula I: | 2022-05-19 |
20220153693 | SUBSTITUTED MONO- AND POLY-PHENYL-CORE MONOMERS AND POLYMERS THEREOF FOR VOLUME BRAGG GRATINGS - The disclosure provides recording materials including mono- or poly-phenyl-core derivatized monomers and polymers for use in volume Bragg gratings, including, but not limited to, volume Bragg gratings for holography applications. Several structures are disclosed for mono- or poly-phenyl-core derivatized monomers and polymers for use in Bragg gratings applications, leading to materials with higher refractive index, low birefringence, and high transparency. The disclosed mono- or poly-phenyl-core derivatized monomers and polymers thereof can be used in any volume Bragg gratings materials, including two-stage polymer materials where a matrix is cured in a first step, and then the volume Bragg grating is written by way of a second curing step of a monomer. | 2022-05-19 |
20220153694 | MODIFIED AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND SELECTED PSYCHIATRIC DISORDERS - 2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2-oxopyrrolidin-1-yl)propanamide derivatives with R-configuration at the stereogenic center are disclosed, showing broad-spectrum protective activity in animal models of epileptic seizures, pain, depression and anxiety that are simultaneously devoid of undesirable sedative effects. Additionally, the disclosed derivatives have neuroprotective effects in the in vitro and in vivo studies. | 2022-05-19 |
20220153695 | Compounds for the Treatment Of Acute and Chronic Kidney Disease - The present disclosure is concerned with biaryl aminomaleimide compounds for the treatment of disorders associated with heme oxygenase-1 (HO-1) signaling dysfunction such as, for example, kidney diseases (e.g., chronic kidney disease, acute kidney injury). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 2022-05-19 |
20220153696 | Hydrazinyl-Pyrrolo Compounds and Methods for Producing a Conjugate - The present disclosure provides conjugate structures and hydrazinyl-pyrrolo compound structures used to produce these conjugates. The disclosure also encompasses methods of production of such conjugates, as well as methods of using the same. | 2022-05-19 |
20220153697 | RIGIDIFIED PENTADENTATE CHELATING AGENTS USEFUL FOR THE [AL18F]2+ LABELLING OF BIOMOLECULES - Rigidified pentadentate chelating agents of Formulae (I) and (II), which are useful for the [Al | 2022-05-19 |
20220153698 | NOVEL COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, SELF-HEALING MATERIAL, SURFACE COATING AGENT, PAINT, ADHESIVE, MATERIAL FOR BATTERY AND CURED PRODUCT - Provided is a compound, which is represented by the following general formula (1): | 2022-05-19 |
20220153699 | SYNTHESIS OF 4-AMINO-5-METHYL-1H-PYRIDIN-2(1H)-ON (INTERMEDIATE COMPOUND FOR THE SYNTHESIS OF THE MR ANTAGONIST FINERENONE) FROM 2-CHLORO-5-METHYL-4-NITRO-PYRIDINE-1-OXIDE USING THE INTERMEDIATE COMPOUND 2-CHLORO-5-METHYL-4-PYRIDINAMINE - The present invention relates to a novel and improved method for preparing 4-amino-5-methylpyridone of the formula (I) | 2022-05-19 |
20220153700 | SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT - Provided are omecamtiv mecarbil dihydrochloride salt forms, compositions and pharmaceutical formulations thereof, and methods for their preparation and use. | 2022-05-19 |
20220153701 | PROCESS FOR PREPARING 4-AMINO-5-METHYLPYRIDONE - The present invention provides a method for preparing the process intermediate 4-amino-5-methylpyridone of the formula (I), characterized in that the intermediate 4-hydroxy-5-methyl-1H-pyridin-2-one of the formula (III) is reacted with ammonia in an autoclave with addition of an ammonium bromide salt. | 2022-05-19 |
20220153702 | Compounds for the Treatment Of Acute and Chronic Kidney Disease - The present disclosure is concerned with thioquinolinone compounds for the treatment of disorders associated with heme oxygenase-1 (HO-1) signaling dysfunction such as, for example, kidney diseases (e.g., chronic kidney disease, acute kidney injury). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 2022-05-19 |
20220153703 | ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE - The present invention is directed to novel compounds of Formula (I), or a pharmaceutically acceptable salt, solvate or hydrate thereof. Pharmaceutical compositions comprising a compound of Formula (I), or a pharmaceutically acceptable salt, solvate or hydrate thereof, are also described. The invention is also directed to use of the compounds of Formula (I) for treating a condition in a mammal associated with AhR imbalance, such as an inflammatory disease or disorder. | 2022-05-19 |
20220153704 | CRYSTAL FORM E OF BULLEYACONITINE A, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF - Provided is a crystal form E of bulleyaconitine A and a preparation method for the crystal form E of bulleyaconitine A. An X-ray powder diffraction spectrum of the crystal form measured by Cu-Kα-ray is as shown in FIG. | 2022-05-19 |
20220153705 | AMINOBENZIMIDAZOLE DERIVATIVES, TREATMENTS, AND METHODS OF INHIBITING HISTONE DEACETYLASE - The present invention is directed to novel aminobenzimidazole derivatives. The present invention is also directed to methods of treating a histone deacetylase (HDAC)-associated disease or inhibiting the histone deacetylating activity of a HDAC isoform in a cell or with one or more of the aminobenzimidazole derivatives. | 2022-05-19 |
20220153706 | INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 - The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer. | 2022-05-19 |
20220153707 | CRYSTAL FORM OF TETRAMETHYLPYRAZINE NITRONE, PREPARATION METHOD AND USE THEREOF - A crystal form of tetramethylpyrazine nitrone (TBN), and a preparation method and use thereof is provided. A crystal form A of TBN has characteristic diffraction peaks in the XRPD pattern at 2θ°: 10.60±0.2, 11.03±0.2, 15.31±0.2, 15.55±0.2, 17.14±0.2, 17.93±0.2, and 23.81±0.2. The crystal form A has low risk of polymorphism transformation and good stability, which contribute to the stability of the preparations during the production and storage processes, and effectively guarantee the consistency of the content of the crystal form in the preparations. Therefore, the preparations are safe, effective, and controllable in quality. Also, the crystal form A has high biological activity, good druggability, and high bioavailability, fast onset of action. | 2022-05-19 |
20220153708 | TWO PIECE SENSOR ASSEMBLY AND METHOD OF USE - Disclosed herein is a two-piece sensor assembly that includes an attachment collar configured to attach to a body surface of a patient and comprising at least one opening, and a skin sensor configured to seat into the at least one opening in the attachment collar. The skin sensor includes at least one radiation source configured to irradiate the body surface with at least one interrogation light, at least one detector configured to detect at least one response light incident from the direction of the body surface, and a controller communicatively coupled to the skin sensor, the attachment collar or both, wherein the controller is programed to transmit information and to receive information between the controller and the skin sensor and/or the attachment collar, and to control the at least one radiation source and the at least one detector. | 2022-05-19 |
20220153709 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS - The present disclosure provides compounds represented by Formula I: | 2022-05-19 |
20220153710 | Compounds - A compound of formula (I), or a pharmaceutical salt thereof: | 2022-05-19 |
20220153711 | P14-Kinase Inhibitors and Methods of Using the Same - Compounds and methods are provided for inhibiting a PI4-kinase Methods of treating a pathogen infection and methods of treating cancer are also provided. The PI4-kinase inhibitor can be a compound that is a 5-aryl or heteroaryl-thiazole, e.g., as described herein. In certain embodiments, the PI4-kinase inhibitor is a substituted 2-amino-5-phenylthiazole or substituted 2-amino-5-pyridylthiazole compound. In some embodiments, the compounds have broad spectrum anti-infective activity against a variety of infective diseases, where the diseases are caused by pathogens containing a basic amino acid PIP-2 pincer (BAAPP) domain that interacts with phosphatidylinositol 4,5-bisphosphate (PIP-2) to mediate pathogen replication. Also provided are methods of treating a subject for cancer using a PI4-kinase inhibitor. Aspects of the methods include inhibiting PI4-kinase in a cancer cell to reduce cellular proliferation. | 2022-05-19 |
20220153712 | PROCESS FOR PRODUCING A POLYBENZOXAZINE MONOMER - A process for manufacturing a polybenzoxazine monomer, crosslinking the latter, and using the crosslinked product to form an ablative thermal protection system for a thruster nozzle or atmospheric reentry body. | 2022-05-19 |
20220153713 | HYDRAZONE AMIDE DERIVATIVE AND APPLICATION THEREOF IN PREPARATION OF MEDICAMENTS FOR PREVENTING AND TREATING ALOPECIA - The present disclosure provides a brand-new hydrazone amide derivative and an application thereof in preparation of medicaments for preventing and treating alopecia. The structural formula of the hydrazone amide derivative is shown in formula (I), and the hydrazone amide derivative is a brand-new compound for stimulating hair follicle growth and preventing and treating alopecia. | 2022-05-19 |
20220153714 | SMALL MOLECULE PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY - The invention relates to small photosensitizers, their process of preparation and uses of the compounds in optical imaging and photodynamic therapy. The invention provides a compound of formula (I), a derivative or a salt thereof Wherein R1 is selected from the group consisting of amines, anilines, phenols, thiophenols, selenols and aryl groups; R2 and R3 independently are H or halogen; R4 is selected from the group consisting of H, nitre and cyano: and R5 and R6 independently are either absent or oxygen or methyl. | 2022-05-19 |
20220153715 | PURIFIED 2,5-FURANDICARBOXYLIC ACID PATHWAY PRODUCTS - The present disclosure provides processes for the purification of 2,5-furandicarboxylic acid (FDCA). The present disclosure further provides crystalline preparations of purified FDCA, as well as processes for making the same. In addition, the present disclosure provides mixtures used in processes for the purification of FDCA. | 2022-05-19 |
20220153716 | SYSTEM AND METHOD FOR THE EXTRACTION OF ISOFLAVONES FROM SOYBEANS - The present disclosure describes a system for the commercial scale extraction of isoflavones from soybean meal. The system includes an optional grinder, an extraction component, a solid-liquid separation component, an acid hydrolysis component, a neutralization component, and a purification component. Also provided are methods of commercial scale extraction of one or more isoflavones from soybean meal. The method includes extracting an isoflavone glucoside from soybean meal, hydrolyzing the isoflavone glucoside to obtain an isoflavone aglycone, neutralizing the isoflavone aglycone, and purifying the isoflavone aglycone. | 2022-05-19 |
20220153717 | System, Method and Apparatus for Cannabinoid Tincture Separation and Solvent Recovery - A system for processing cannabinoids and recovering solvent has a vessel for a mixture of cannabinoids and solvent. A pump forms a vacuum in the system to draw the mixture into a first heat exchanger to pre-heat the mixture. A falling film evaporator receives the mixture from the first heat exchanger, and boils the mixture to form a solvent vapor. The falling film evaporator collects the cannabinoids from the mixture as a crude oil. The first heat exchanger receives the solvent vapor. Heat is transferred to incoming mixture of the system, and cools and condenses the solvent vapor to form solvent condensate and vapor. A second heat exchanger receives and further cools the solvent condensate and vapor to form further condensed solvent and some solvent vapor. The pump receives the further condensed solvent and some solvent vapor and increases pressure to form solvent liquid and recovers solvent liquid for reuse. | 2022-05-19 |
20220153718 | SYNTHESIS OF STABLE AMORPHOUS APALUTAMIDE - The present invention relates to a process for the preparation of apalutamide in stable amorphous form. The invention also relates to a novel intermediate crystalline form, called form X, which gives rise to said amorphous form, and a process for obtaining said form X. | 2022-05-19 |
20220153719 | GPR119 AGONISTS - This disclosure is directed, at least in part, to GPR119 agonists useful for the treatment of conditions or disorders involving the gut-brain axis. In some embodiments, the GPR119 agonists are gut-restricted compounds. In some embodiments, the condition or disorder is a metabolic disorder, such as diabetes, obesity, nonalcoholic steatohepatitis (NASH), or a nutritional disorder such as short bowel syndrome. | 2022-05-19 |
20220153720 | IRE1ALPHA INHIBITORS AND USES THEREOF - Disclosed herein, inter alia, are compounds for inhibiting IRE1α and uses thereof. | 2022-05-19 |
20220153721 | MAGL INHIBITORS - Provided herein are substituted 1,1,1,3,3,3-hexafluoropropan-2-yl 6-azaspiro[2.5]octane-6-carboxylate compounds and pharmaceutical compositions comprising said compounds. The compounds and compositions provided herein are useful as inhibitors of MAGL. Furthermore, the compounds and compositions as provided herein are useful for the treatment of diseases and disorders benefiting from the inhibition of MAGL. | 2022-05-19 |
20220153722 | CDK2/5 DEGRADERS AND USES THEREOF - The present invention relates to bifunctional compounds, compositions, and methods for treating diseases or conditions mediated by dysfunctional cyclin-dependent kinase 2 (CDK2) and CDK5 activity. | 2022-05-19 |
20220153723 | IRE1ALPHA INHIBITORS AND USES THEREOF - Disclosed herein, inter alia, are compounds for inhibiting IRE1α and uses thereof. | 2022-05-19 |
20220153724 | Inhibitors Of Plasma Kallikrein - The present invention provides compounds of formula (I), | 2022-05-19 |
20220153725 | HERBICIDALLY ACTIVE 4-(4-TRIFLUORMETHYL-6-CYCLOROPYLPYRAZOLYL)PYRIMIDINES - The invention relates to 4-(4-trifluormethyl-6-cycloropylpyrazolyl)pyrimidines of general formula (I) and to their agrochemically acceptable salts, and to the use thereof in the field of plant protection. | 2022-05-19 |
20220153726 | PHARMACEUTICAL FORMULATIONS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PY- RIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMINDE AND SALTS THEREOF - A pharmaceutical formulation of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide (compound 1), in particular methanesulfonic acid salt thereof, and methods of using the pharmaceutical formulation for the treatment or prevention of diseases or medical conditions mediated through mutated forms of epidermal growth factor receptor (EGER), such as various cancers, are disclosed. | 2022-05-19 |
20220153727 | METHOD FOR PRODUCING PYRROLE-IMIDAZOLE (POLY)AMIDE - The purpose of the present invention is to provide a method for producing a pyrrole-imidazole (poly)amide compound with the rapidly improved conversion rates, high yield and high reproducibility in the reaction forming an amide bond between a carboxy group binding to a pyrrole and an amino group binding to an imidazole. A method for producing a pyrrole-imidazole (poly)amide by reacting an aminoimidazole carboxylic acid derivative with a pyrrolecarboxylic acid derivative in the presence of a heterocyclic aromatic compound as a solvent. | 2022-05-19 |
20220153728 | COMPOUNDS, COMPOSITIONS AND METHODS - The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or mixture of stereoisomers thereof, and methods of making and using thereof. | 2022-05-19 |
20220153729 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS - Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention. | 2022-05-19 |
20220153730 | INHIBITORS OF C-JUN-N-TERMINAL KINASE (JNK) - The present invention provides novel compounds according to Formula (I): | 2022-05-19 |
20220153731 | Compounds for Pain Treatment, Compositions Comprising Same, and Methods of Using Same - The invention relates to compounds of formula (I), compositions containing the same, and methods for treating and/or diminishing pain in a subject in need thereof. The compounds of formula (I) are effective for treating opioid-induced tachyphylaxis and opioid-induced hyperalgesia. | 2022-05-19 |
20220153732 | PROTEIN SECRETION INHIBITORS - Provided herein are secretion inhibitors, such as inhibitors of Sec61, methods for their preparation, related pharmaceutical compositions, and methods for using the same, wherein the compound has a structure of Formula (I), (II), or (III). | 2022-05-19 |
20220153733 | SUBSTITUTED TETRAHYDROPYRANS AS CCR2 MODULATORS - Compounds are provided that are modulators of the CCR2 receptor. The compounds have the general formula (Ia1′): | 2022-05-19 |